Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Marampon

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Journal of Hematology & Oncology|March 1, 2018
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaClaudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.
Cancers|October 24, 2019
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Cells|November 27, 2021
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal RhabdomyosarcomaSimona Camero, Giulia Vitali, Paola Pontecorvi, et al.
Frontiers in Oncology|October 17, 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of doseSimona Camero, Matteo Cassandri, Silvia Pomella, et al.
Head & Neck|July 13, 2023
Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapyFrancesca De Felice, Maria Serpone, Carlo Guglielmo Cattaneo, et al.
Journal of Geriatric Oncology|July 30, 2023
Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck regionFrancesca De Felice, Maria Serpone, Carlo Guglielmo Cattaneo, et al.
Molecular Biology of the Cell|March 28, 2008
Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaBFrancesco Marampon, Mathew C Casimiro, Maofu Fu, et al.
Cancers|December 31, 2025
RETRACTED: Gravina et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. <i>Cancers</i> 2019, <i>11</i>, 1604Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Frontiers in Pharmacology|April 11, 2022
The Botanical Drug PBI-05204, a Supercritical CO<sub>2</sub> Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human GlioblastomaAlessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.
Endocrine-Related Cancer|March 20, 2013
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancerGiovanni Luca Gravina, Francesco Marampon, Paola Muzi, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Journal of Hematology & Oncology|March 1, 2018
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastomaClaudio Festuccia, Andrea Mancini, Alessandro Colapietro, et al.
Cancers|October 24, 2019
The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine ModelsGiovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Cells|November 27, 2021
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal RhabdomyosarcomaSimona Camero, Giulia Vitali, Paola Pontecorvi, et al.
Frontiers in Oncology|October 17, 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of doseSimona Camero, Matteo Cassandri, Silvia Pomella, et al.
Head & Neck|July 13, 2023
Surgery-ineligible elderly patients with cutaneous squamous cell carcinoma of the head and neck region gain clinical benefit from definitive weekly hypofractionated radiotherapyFrancesca De Felice, Maria Serpone, Carlo Guglielmo Cattaneo, et al.
Journal of Geriatric Oncology|July 30, 2023
Definitive weekly hypofractionated radiotherapy in surgery-ineligible older adults with cutaneous squamous cell carcinoma of the head and neck regionFrancesca De Felice, Maria Serpone, Carlo Guglielmo Cattaneo, et al.
Molecular Biology of the Cell|March 28, 2008
Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaBFrancesco Marampon, Mathew C Casimiro, Maofu Fu, et al.
Cancers|December 31, 2025
RETRACTED: Gravina et al. The Brain Penetrating and Dual TORC1/TORC2 Inhibitor, RES529, Elicits Anti-Glioma Activity and Enhances the Therapeutic Effects of Anti-Angiogenetic Compounds in Preclinical Murine Models. <i>Cancers</i> 2019, <i>11</i>, 1604Giovanni Luca Gravina, Andrea Mancini, Alessandro Colapietro, et al.
Frontiers in Pharmacology|April 11, 2022
The Botanical Drug PBI-05204, a Supercritical CO<sub>2</sub> Extract of Nerium Oleander, Is Synergistic With Radiotherapy in Models of Human GlioblastomaAlessandro Colapietro, Peiying Yang, Alessandra Rossetti, et al.
Endocrine-Related Cancer|March 20, 2013
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancerGiovanni Luca Gravina, Francesco Marampon, Paola Muzi, et al.
Pageof 16